文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

推进癌症治疗：免疫检查点抑制剂及联合策略综述

Advancing Cancer Treatment: A Review of Immune Checkpoint Inhibitors and Combination Strategies.

作者信息

Mc Neil Valencia, Lee Seung Won

机构信息

Department of Precision Medicine, Sungkyunkwan University School of Medicine, Suwon 16419, Republic of Korea.

Department of Artificial Intelligence, Sungkyunkwan University, Suwon 16419, Republic of Korea.

出版信息

Cancers (Basel). 2025 Apr 23;17(9):1408. doi: 10.3390/cancers17091408.

DOI:10.3390/cancers17091408
PMID:40361336
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12071127/
Abstract

A groundbreaking milestone in oncology has been the recognition and targeted elimination of malignant cells through cancer immunotherapy, which harnesses the body's immune system to attack cancer [...].

摘要

肿瘤学领域的一个开创性里程碑是通过癌症免疫疗法识别并靶向清除恶性细胞，该疗法利用人体免疫系统来攻击癌症[...]。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c38f/12071127/6825808e8864/cancers-17-01408-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c38f/12071127/9c6dfa51671a/cancers-17-01408-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c38f/12071127/6825808e8864/cancers-17-01408-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c38f/12071127/9c6dfa51671a/cancers-17-01408-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c38f/12071127/6825808e8864/cancers-17-01408-g002.jpg

相似文献

[1]
Advancing Cancer Treatment: A Review of Immune Checkpoint Inhibitors and Combination Strategies.

Cancers (Basel). 2025-4-23

[2]
Research Progresses in Immunological Checkpoint Inhibitors for Breast Cancer Immunotherapy.

Front Oncol. 2021-9-23

[3]
The Development of Immunotherapy for the Treatment of Recurrent Glioblastoma.

Cancers (Basel). 2023-8-29

[4]
Phase I study of VSV-GP (BI 1831169) as monotherapy or combined with ezabenlimab in advanced and refractory solid tumors.

Future Oncol. 2022-8

[5]
Combination of oncolytic Maraba virus with immune checkpoint blockade overcomes therapy resistance in an immunologically cold model of advanced melanoma with dysfunctional T-cell receptor signalling.

J Immunother Cancer. 2024-7-25

[6]
Oncolytic viruses combined with immune checkpoint therapy for colorectal cancer is a promising treatment option.

Front Immunol. 2022

[7]
Traditional Treatment Approaches and Role of Immunotherapy in Lung Malignancy and Mesothelioma.

Cancer Treat Res. 2023

[8]
Prospects and Challenges of Immunotherapy for Thyroid Cancer.

Endocr Pract. 2025-3

[9]
Advancing Breast Cancer Treatment: The Role of Immunotherapy and Cancer Vaccines in Overcoming Therapeutic Challenges.

Vaccines (Basel). 2025-3-24

[10]
Advances in immunotherapy for mucosal melanoma: harnessing immune checkpoint inhibitors for improved treatment outcomes.

Front Immunol. 2024

引用本文的文献

[1]
Cancer complexity: why we need a novel cancer research strategy.

Front Oncol. 2025-8-1

[2]
Liver metastasis of colorectal cancer: Mechanism and clinical therapy (Review).

Oncol Rep. 2025-10

本文引用的文献

[1]
Real-World Study of Systemic Treatment after First-Line Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma in Asia-Pacific Countries.

Liver Cancer. 2024-8-20

[2]
Advances in preclinical and clinical studies of oncolytic virus combination therapy.

Front Oncol. 2025-2-7

[3]
Optimal immunotherapy duration in advanced NSCLC: defining the ideal treatment window.

Cancer Biol Med. 2025-2-10

[4]
Enhancing immunotherapy efficacy with synergistic low-dose radiation in metastatic melanoma: current insights and prospects.

J Exp Clin Cancer Res. 2025-1-30

[5]
Glutamine and cancer: metabolism, immune microenvironment, and therapeutic targets.

Cell Commun Signal. 2025-1-24

[6]
Gut Microbiome Modulation in Hepatocellular Carcinoma: Preventive Role in NAFLD/NASH Progression and Potential Applications in Immunotherapy-Based Strategies.

Cells. 2025-1-9

[7]
Role of the androgen receptor in melanoma aggressiveness.

Cell Death Dis. 2025-1-21

[8]
Clinical advances of mRNA vaccines for cancer immunotherapy.

Med. 2025-1-10

[9]
The evolution of cancer immunotherapy: a comprehensive review of its history and current perspectives.

Korean J Clin Oncol. 2024-12

[10]
Current trends in sensitizing immune checkpoint inhibitors for cancer treatment.

Mol Cancer. 2024-12-26

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索